Finally, the protective effect of SHBG against NAFLD development persists in castrated mouse models, supporting our findings that TT is not driving the association of SHBG with NAFLD [16]. The gene discussed is SHBG; the disease is metabolic dysfunction-associated steatotic liver disease.